FDA inspection
SmithKline Beecham Pharma GmbH & co. KG: FDA inspection ending Mar 15, 2024
FDA inspection 1233707 · Voluntary Action Indicated (VAI) · Dresden
Key facts
| Inspection ID | 1233707 |
|---|---|
| Firm | SmithKline Beecham Pharma GmbH & co. KG |
| FEI number | 3004835618 |
| Address | Zirkusstr. 40 |
| City | Dresden |
| Country | Germany |
| Fiscal year | 2024 |
| Inspection end date | Mar 15, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Vaccines and Allergenic Products |
| Product type | Biologics |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data